CTSI Translational Accelerator Research Funding [Restricted to Duke Faculty Only]

Funding Agency:
Duke University

The Duke CTSI Translational Accelerator Research Funding Agreement provides funding up to $150,000 (direct costs only) to support novel clinical and translational research in its many forms. Projects must demonstrate high translational potential with a clear path to subsequent financial support, new company formation, licensing, not-for-profit partnering, or other channels to enable translation to the patient care.  

Cross-disciplinary scientific research addressing the development of therapies, diagnostics or devices applicable to human disease, clinical research/trials (excluding Phase 2 or beyond), epidemiological studies, and/or community-based research are eligible for these awards.  Population health improvement projects should demonstrate significant stakeholder involvement to advance applicability of the results to broader practice patterns, clinical guidelines, and other applications.  Proposals from teams of investigators from different disciplines are encouraged.

Deadlines:

  • Letter of Intent (Optional): September 15, 2017
  • Application Submission Deadline: November 6, 2017

Agency Website

Areas of Interest

Duke CTSI is interested in the following types of translational research projects, with an emphasis on inter-disciplinary collaborations that test generalizable solutions to translational research problems:

  • Research that applies or accelerates discovery into testing in clinical or population settings.
  • Development and/or evaluation of the evidence base that changes practice.
  • Research that impacts how practice improves health policy, health outcomes, and the health of populations.

Projects must demonstrate high translational potential with a clear path to subsequent financial support, new company formation, licensing, not-for-profit partnering, or other channels to enable translation to the patient care.  Cross-disciplinary scientific research addressing the development of therapies, diagnostics or devices applicable to human disease, clinical research/trials (excluding Phase 2 or beyond), epidemiological studies, and/or community-based research are eligible for these awards.  Population health improvement projects should demonstrate significant stakeholder involvement to advance applicability of the results to broader practice patterns, clinical guidelines, and other applications.  Proposals from teams of investigators from different disciplines are encouraged.  

The Primary source of funding is from Duke's Clinical and Translational Science Award (CTSA)

Eligibility Requirements

  • Proposals must be submitted by Duke regular rank faculty and comply with the Duke University Policy on PI Status in the Duke Faculty Handbook. Researchers holding an adjunct appointment are not eligible to apply.
  • Non-Duke faculty may be named as co-investigators if they have a separate aim that will be funded by their local CTSA (subcontracts to other institutions are not allowed under this award).
  • More than one proposal may be submitted per faculty member acting as PI, but the faculty member is only eligible to receive one award as PI during a given funding cycle.
  • Faculty members may not serve as PI concurrently on the Transformative and Translational Duke CTSI awards.

Amount

$150,000

Funding Type

Grant

Eligibility

Faculty

Category

Interdisciplinary
Medical
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

November 6, 2017